According to the new market research report “Surgical Sealants Market by Product (Natural & Synthetic, Fibrin, Collagen, Gelatin, Cyanoacrylate, Albumin, Human blood), Indication (Hemostasis, Tissue Sealing), Application (CNS, Cardiovascular, Cosmetic Surgery) – Global Forecast to 2021”, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
Don’t miss out on business opportunities in Surgical Sealants Market
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=38230314
The Surgical Sealants Market witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 9.6% between 2016 and 2021 to reach 2.96 Billion by 2021.
The growth in this market is majorly attributed to factors such as increasing need to manage blood loss in patients, growing rate of surgeries being performed annually, greater uptake of technologically advanced products, and increasing FDA and CE Mark approvals. Moreover, factors like rising geriatric population, increasing prevalence and incidence of chronic disorders, and increasing trauma and accident cases are driving the adoption of these sealants and adhesives. Browse and in-depth TOC on ” Surgical Sealants Market ”
212 – Tables
41 – Figures
265 – Pages
View more detailed TOC @
The Surgical Sealants Market is segmented on the basis of product, indication, application, and region. On the basis of product, the market is segmented into natural/biological sealants and adhesives and synthetic & semi-synthetic sealants and adhesives. The natural/biological sealants and adhesives segment is further divided on the basis of type and origin.
On the basis of type, natural/biological sealants have been segmented into polypeptide/protein-based and polysaccharide-based sealants and adhesives. The polypeptide/protein-based sealants segment consists of fibrin, gelatin, collagen, and albumin-based adhesives, while the polysaccharide-based sealants segment comprises of chitosan-based and other polysaccharide-based adhesives.
On the basis of origin, the natural/biological sealants and adhesives segment have been categorized into human blood and animal-based adhesives. The synthetic and semi-synthetic sealants and adhesives have been segmented into cyanoacrylates, polyethylene glycol hydrogels, urethane-based adhesives, and other synthetic adhesives.
On the basis of indication, the Surgical Sealants Market has been segmented into surgical hemostasis, tissue sealing, and tissue engineering. Based on application, the market is segmented into CNS, general, cardiovascular, orthopedic, cosmetic, urological, pulmonary, ophthalmic surgeries, and other applications.
In 2016, North America is expected to account for the largest share of the market. The largest share of this regional segment is driven by rising healthcare expenditure, the presence of many large and well-equipped hospitals, greater uptake of technologically advanced medical products, increasing FDA approvals for surgical sealants, and the presence of major market players in this region.
However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to growing per capita income, increasing medical tourism, the presence of less stringent regulations, and growing demand for quality healthcare. In addition, increasing investments by major players in this region is propelling the market further.
Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=38230314
Baxter International, Inc. (U.S.), Johnson & Johnson (Ethicon, Inc.; U.S.), CryoLife, Inc. (U.S.), and C.R. Bard, Inc. (U.S.) held the major share of the Surgical Sealants Market and will continue to dominate the market between 2016 and 2021.
Some of the major players operating in this market are Medtronic plc (U.S.), Sanofi Group (France), B. Braun Melsungen AG (Germany), Cohera Medical, Inc. (U.S.), Ocular Therapuetix, Inc. (U.S.), Vivostat A/S (Denmark), and Sealantis Ltd. (Israel).
Medical Devices Market Research Reports & Consulting
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/surgical-sealants-adhesives-market.asp
Visit Our Website: https://www.marketsandmarkets.com